By analyzing TCGA STAD-ESCA data, Zhang et al. found that the dMMR/MSI-H subtype had a higher tumor mutation burden (TMB) but no relationship with the lymphocyte infiltration signature score or CD8+ T-cell abundance [46]. The gene discussed is CD8A; the disease is neoplasm.